Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Gastrointestinal events in rheumatoid arthritis: time for the lower gastrointestinal tract!

Nurmohamed MT.

J Rheumatol. 2012 Jul;39(7):1317-9. doi: 10.3899/jrheum.120461. No abstract available.

PMID:
22753799
2.

Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis.

Vega-Morales D, Barrón-Almazán M, Arana-Guajardo A.

Ann Rheum Dis. 2014 Mar;73(3):e14. doi: 10.1136/annrheumdis-2013-204895. Epub 2013 Dec 13. No abstract available.

PMID:
24336339
3.

Managing comorbidity risks in rheumatoid arthritis.

Dechant SA, Matteson EL.

Curr Opin Rheumatol. 2004 May;16(3):177-9. No abstract available.

PMID:
15103241
4.

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis.

Laine L, Bombardier C, Hawkey CJ, Davis B, Shapiro D, Brett C, Reicin A.

Gastroenterology. 2002 Oct;123(4):1006-12.

PMID:
12360461
5.

Response to: 'Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis' by Vega-Morales et al.

Dougados M.

Ann Rheum Dis. 2014 Mar;73(3):e15. doi: 10.1136/annrheumdis-2013-204954. Epub 2013 Dec 13. No abstract available.

PMID:
24336333
6.

Co-morbidity in rheumatoid arthritis.

Mikuls TR.

Best Pract Res Clin Rheumatol. 2003 Oct;17(5):729-52. Review.

PMID:
12915155
8.

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C.

Gastroenterology. 2003 Feb;124(2):288-92.

PMID:
12557133
9.

Serious gastrointestinal events from low dose analgesic use.

Peura DA.

J Rheumatol. 2004 May;31(5):1009-10; author reply 1010-1. No abstract available.

11.
12.

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.

Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF.

Arch Intern Med. 1996 Jul 22;156(14):1530-6.

PMID:
8687261
14.

Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.

Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M; REAL Study Group..

J Rheumatol. 2011 Jul;38(7):1258-64. doi: 10.3899/jrheum.101009. Epub 2011 Apr 15.

PMID:
21498482
15.

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.

McKendry RJ, Dale P.

J Rheumatol. 1993 Nov;20(11):1850-6.

PMID:
8308769
16.

Co-morbidities in established rheumatoid arthritis.

Gullick NJ, Scott DL.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):469-83. doi: 10.1016/j.berh.2011.10.009. Review.

PMID:
22137918
17.

Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis.

Schnabel A, Herlyn K, Burchardi C, Reinhold-Keller E, Gross WL.

Rheumatol Int. 1996;15(5):195-200.

PMID:
8717103
18.

[Incidence of internal organ diseases in patients with rheumatoid arthritis].

Juszczyk T, Piotrowska D, Pakuła A.

Reumatologia. 1979;17(3):321-6. Polish. No abstract available.

PMID:
515578
19.

A SURVEY OF FOUR HUNDRED AND SIX CASES OF RHEUMATOID ARTHRITIS.

GIBBERD FB.

Acta Rheumatol Scand. 1965;11:62-70. No abstract available.

PMID:
14308112
20.

Supplemental Content

Support Center